The impact of insurance on access to cancer clinical trials at a comprehensive cancer center

Clinical Cancer Research

Volumn 16, Issue 24, 2010, Pages 5997-6003

  Klamerus, Justin F ^a   Bruinooge, Suanna S ^b   Ye, Xiaobu ^a   Klamerus, Mandi L ^c   Damron, Dorothy ^a   Lansey, Dina ^a   Lowery, John C ^a   Diaz Jr , Luis A ^a   Ford, Jean G ^a   Kanarek, Norma ^a   Rudin, Charles M ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CENTER; CANCER RESEARCH; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; PATIENT PARTICIPATION; PRIORITY JOURNAL;

CANCER CARE FACILITIES; COMPREHENSIVE HEALTH CARE; ETHNIC GROUPS; FEMALE; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIAL CLASS; UNITED STATES;

EID: 78649643165     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1451     Document Type: Article

References (20)

1. Cancer Statistics Review SEER. 1975-2006, based on November 2008 SEER data submission. Bethesda (MD): National Cancer Institute; 2009. Available from: www.seer.cancer.gov.
2. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst 2007;99:1384-94.
3. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-205.
4. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
5. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
7. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting under-represented populations to cancer clinical trials: a systematic review. Cancer 2008;112:228-42.
8. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-17.
9. Howerton MW, Gibbons MC, Baffi CR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 2007;109:465-76.
10. Schnipper LE, Meropol NJ, Brock DW. Value and cancer care: towards an equitable future. Clin Cancer Res 2010;16:6004-8.
11. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008;58:9-31.
12. Unger JM, Coltman CAJr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006;24:141-4.
13. Gross CP, Krumholz HM. Impact of managed care on cancer trial enrollment. J Clin Oncol 2005;23:3811-8.
14. Lara PN Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 2005;23:9282-9.
15. Dalton WS, Sullivan DM, Yeatman TJ, Fenstermacher DA. The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally. Clin Cancer Res 2010;16:5987-96.
16. Djulbegovic B, Kumar A, Soares HP, et al. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med 2008;168:632-42.
17. Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med 2005;352:895-904.
18. Fireman BH, Fehrenbacher L, Gruskin EP, Ray GT. Cost of care for patients in cancer clinical trials. J Natl Cancer Inst 2000;92:136-42.
19. Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA 2003;289:2970-7.
20. Wagner JL, Alberts SR, Sloan JA, et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst 1999;91:847-53.